206 related articles for article (PubMed ID: 34035838)
1. Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis.
Surov A; Wienke A
Ther Adv Med Oncol; 2021; 13():17588359211008844. PubMed ID: 34035838
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia predicts overall survival in patients with malignant hematological diseases: A meta-analysis.
Surov A; Wienke A
Clin Nutr; 2021 Mar; 40(3):1155-1160. PubMed ID: 32768316
[TBL] [Abstract][Full Text] [Related]
3. Low skeletal muscle mass in cholangiocarcinoma treated by surgical resection. A meta-analysis.
Surov A; Pech M; Omari J; Melekh B; March C; Perrakis A; Wienke A
HPB (Oxford); 2022 Jul; 24(7):997-1006. PubMed ID: 34906379
[TBL] [Abstract][Full Text] [Related]
4. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
Surov A; Pech M; Gessner D; Mikusko M; Fischer T; Alter M; Wienke A
Clin Nutr; 2021 Oct; 40(10):5298-5310. PubMed ID: 34536638
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients.
Surov A; Wienke A
JPEN J Parenter Enteral Nutr; 2022 Nov; 46(8):1761-1768. PubMed ID: 35633306
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation.
Haehl E; Alvino L; Rühle A; Zou J; Fabian A; Grosu AL; Nicolay NH
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428629
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer - a Meta-analysis.
Thormann M; Hinnerichs M; Barajas Ordonez F; Saalfeld S; Perrakis A; Croner R; Omari J; Pech M; Zamsheva M; Meyer HJ; Wienke A; Surov A
Acad Radiol; 2023 Aug; 30(8):1552-1561. PubMed ID: 36564257
[TBL] [Abstract][Full Text] [Related]
9. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis.
Findlay M; White K; Stapleton N; Bauer J
Clin Nutr; 2021 Apr; 40(4):1711-1718. PubMed ID: 32994071
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis.
March C; Omari J; Thormann M; Pech M; Wienke A; Surov A
Clin Nutr ESPEN; 2022 Jun; 49():103-113. PubMed ID: 35623801
[TBL] [Abstract][Full Text] [Related]
11. Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis.
Wong A; Zhu D; Kraus D; Tham T
Laryngoscope; 2021 Feb; 131(2):333-341. PubMed ID: 32220072
[TBL] [Abstract][Full Text] [Related]
12. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.
Rinninella E; Cintoni M; Raoul P; Pozzo C; Strippoli A; Bria E; Tortora G; Gasbarrini A; Mele MC
Clin Nutr; 2020 Jul; 39(7):2045-2054. PubMed ID: 31718876
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy.
Thureau S; Lebret L; Lequesne J; Cabourg M; Dandoy S; Gouley C; Lefebvre L; Mallet R; Mihailescu SD; Moldovan C; Rigal O; Veresezan O; Modzewelski R; Clatot F
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670339
[No Abstract] [Full Text] [Related]
14. Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.
Jogiat UM; Sasewich H; Turner SR; Baracos V; Eurich DT; Filafilo H; Bédard ELR
Ann Surg; 2022 Nov; 276(5):e311-e318. PubMed ID: 35794004
[TBL] [Abstract][Full Text] [Related]
15. The impact of skeletal muscle depletion on older adult patients with head and neck cancer undergoing primary surgery.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
J Geriatr Oncol; 2021 Jan; 12(1):128-133. PubMed ID: 32565144
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia results in poor survival rates in oral cavity cancer patients.
Lin SC; Lin YS; Kang BH; Yin CH; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; She YY; Liu YH; Lee CC
Clin Otolaryngol; 2020 May; 45(3):327-333. PubMed ID: 31769607
[TBL] [Abstract][Full Text] [Related]
17. Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis.
Surov A; Meyer HJ; Wienke A
Oncology; 2022; 100(9):498-504. PubMed ID: 35817000
[No Abstract] [Full Text] [Related]
18. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia Predicts Relevant Clinical Outcomes in Biliary Tract Cancer Patients: A Systematic Review and Meta-Analysis.
Yang L; He Y; Li X
Nutr Cancer; 2022; 74(9):3274-3283. PubMed ID: 35542968
[TBL] [Abstract][Full Text] [Related]
20. Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle.
Galli A; Colombo M; Carrara G; Lira Luce F; Paesano PL; Giordano L; Bondi S; Tulli M; Mirabile A; De Cobelli F; Bussi M
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3489-3502. PubMed ID: 32535862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
